Atrial natriuretic factor in experimental and human hypertension

Eur Heart J. 1988 Jun:9 Suppl H:21-7. doi: 10.1093/eurheartj/9.suppl_h.21.

Abstract

Plasma levels of immunoreactive atrial natriuretic factor (IR-ANF) were evaluated by radioimmunoassay in several models of experimental hypertension and in human hypertension. Plasma levels of IR-ANF are consistently increased in all models of experimental hypertension studied so far. This is accompanied by a decrease of IR-ANF levels in the left atrium at certain times. Plasma levels of IR-ANF are not increased in human essential hypertension, except in the severe form (diastolic blood pressure above 110 mmHg). Peripheral levels of IR-ANF in renovascular hypertension do not differ from normal but are increased above normal in aortic blood.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Atrial Natriuretic Factor / analysis*
  • Atrial Natriuretic Factor / physiology
  • Atrial Natriuretic Factor / therapeutic use
  • Female
  • Heart Atria / analysis
  • Heart Ventricles / analysis
  • Humans
  • Hypertension / drug therapy
  • Hypertension / metabolism*
  • Hypertension / physiopathology
  • Hypertension, Renal / metabolism
  • Male
  • Radioimmunoassay
  • Rats
  • Rats, Inbred SHR
  • Rats, Inbred Strains
  • Rats, Inbred WKY

Substances

  • NPPA protein, human
  • Atrial Natriuretic Factor